Mepolizumab in Episodic Angioedema With Eosinophilia

Stopped Study was closed after the first five participants completed their participation due to lack of efficacy.

Conditions

• Eosinophilia
• Angioedema

Interventions

• BIOLOGICAL: mepolizumab

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)